- Report
- June 2025
- 186 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 277 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 387 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- June 2025
- 196 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- October 2024
- 200 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1344EUR$1,500USD£1,145GBP
- Report
- December 2024
- 201 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- April 2025
- 200 Pages
Global
From €7121EUR$7,950USD£6,070GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1344EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2687EUR$3,000USD£2,291GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- March 2025
- 186 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- March 2025
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- May 2025
- 233 Pages
Global
From €2239EUR$2,500USD£1,909GBP

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more